Incidence and disease burden of autoimmune inflammatory rheumatic diseases after non ‐pharmaceutical interventions in the COVID‐19 era: A nationwide observational study in Korea
ConclusionImplementation of NPIs to contain the pandemic led to a reduction in the incidence of SLE and changed patterns of medical care utilization and treatment cost for most AIRDs.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Je Hee Shin,
Jung Yoon Pyo,
Minkyung Han,
Myeongjee Lee,
Sung Min Lim,
Jee Yeon Baek,
Ji Young Lee,
Ji ‐Man Kang,
InKyung Jung,
Jong Gyun Ahn Tags: ORIGINAL ARTICLE Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Autoimmune Disease | COVID-19 | Health Insurance | Health Management | Insurance | Lupus | Pandemics | Rheumatology | Study